Advertisement

Journal of Cancer Research and Clinical Oncology

, Volume 131, Issue 8, pp 520–526 | Cite as

Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma

  • Sing Yu Goldstein-Jackson
  • Georg Gosheger
  • Günter Delling
  • Wolfgang E. Berdel
  • G. Ulrich. Exner
  • Gernot Jundt
  • Jan-Nicolas Machatschek
  • Andreas Zoubek
  • Heribert Jürgens
  • Stefan S. Bielack
  • for the Cooperative Osteosarcoma Study Group COSS
Original Paper

Abstract

Purpose: The aims of this analysis were to investigate the clinical features of extraskeletal osteosarcoma (ESOS) and examine the outcome after multi-modal therapy. Methods: The co-operative osteosarcoma study-group database was searched for patients with extraskeletal osteosarcoma. Eligible patients were included in a retrospective analysis of patient, tumour and treatment related variables and outcome. As for conventional osteosarcoma, scheduled treatment included surgery and multi-agent chemotherapy. Results: Seventeen eligible patients were identified with a median age of 44 years (range, 3–65 years). The thigh was the commonest tumour site. Two patients had a history of previous malignancies and two had primary metastases. Median follow-up was 3.2 years (range: 0.6–7.4 years) and at last follow-up, 11 patients were alive in complete remission, 3 patients were alive with disease and 3 patients had died of their disease. Three-year overall actuarial and event-free survival rates were 77% and 56%, respectively. Patients with macroscopically complete surgical remission had an improved overall survival (P=0.0004). Conclusions: The patients in this retrospective study had a surprisingly good survival rate. This may be due to the combination of multi-agent chemotherapy with surgery, and we recommend this approach in the treatment of ESOS.

Keywords

Extraskeletal osteosarcoma Chemotherapy 

Notes

Acknowledgements

The studies that form the basis of this work were supported by Deutsche Krebshilfe, Bundesministerium für Forschung und Technologie and Fördergemeinschaft Kinderkrebszentrum Hamburg. S.Y. Goldstein-Jackson received support from the European Community action scheme for the mobility of university students (Erasmus). The authors wish to thank all patients who contributed to the COSS studies and to acknowledge the physicians, nurses, data managers and support staff of the collaborating centres for their active participation. They would like to thank Mathias Kevric for his expert data management. The patients included in this study were from the following hospitals: Universitätsklinikum Münster, Medizinische Klinik und Poliklinik A, Germany; Kinder-Poliklinik, Päd. Onkologie/KMT, Munich; Germany; Medizinische Universitätsklinik, Abteilung Onkologie/Hämatologie, Hamburg, Germany; St. Anna Kinderspital, Vienna, Austria; Medizinische Universitätsklinik I, Cologne, Germany; Medizinische Universitätsklinik, Abteilung Onkologie/Hämatologie, Graz, Austria; Orthopädische Universitätsklinik Balgrist, Zürich, Switzerland; Katharinen – Hospital, Stuttgart; Germany; Medizinische Klinik& Poliklinik V, Heidelberg, Germany; Medizinische Universitätsklinik, Würzburg, Germany; Mutterhaus der Borromäerinnen, Trier, Germany; Medizinische Universitätsklinik I, Abt.: Hämatologie/Internistische Onkologie, Regensburg, Germany; Medizinische Klinik II mit Schwerpunkt Onkologie und Hämatologie, Charité Campus Mitte, Berlin, Germany; Universitätsklinikum Schleswig-Holstein, II. Medizinische Klinik und Poliklinik, Kiel, Germany; Kantonspital Aarau, Abteilung Pädiatrische Onkologie, Aarau, Switzerland; Diakonissenkrankenhaus, Medizinische Klinik II, Stuttgart, Germany; Medizinische Universitätsklinik, Abteilung Hämatologie/Onkologie, Rostock, Germany

References

  1. Ahmad SA, Patel SR, Ballo MT, Baker TP, Yasko AW, Wang X, Feig BW, Hunt KK, Lin PP, Weber KL, Chen LL, Zagars GK, Pollock RE, Benjamin RS, Pisters PWT (2002) Extraosseous osteosarcoma: response to treatment and long-term outcome. J Clin Oncol 20:521–527CrossRefPubMedGoogle Scholar
  2. Bane BL, Evans HL, Ro JY, Carrasco CH, Grignon DJ, Benjamin RS, Ayala AG (1990) Extraskeletal Osteosarcoma: A clinicopathologic review of 26 cases. Cancer 66:2762–2770Google Scholar
  3. Bielack S, Kempf-Bielack B, Schwenzer D et al (1999) Neoadjuvante Therapie des lokalisierten Osteosarkoms der Extremitäten. Erfahrungen der Cooperativen Osteosarkomstudiengruppe COSS an 925 Patienten. Klin Padiatr 211:260–270PubMedGoogle Scholar
  4. Bielack S, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk. An analysis of 1702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 20:776–790CrossRefPubMedGoogle Scholar
  5. Chung EB, Enzinger FM (1987) Extraskeletal osteosarcoma. Cancer 60:1132–1142PubMedGoogle Scholar
  6. Cook PA, Murphy MS, Innis PC, Yu JS (1998) Extraskeletal osteosarcoma of the hand. J Bone Joint Surg (Am) 80:725–729Google Scholar
  7. Covello SP, Humphreys TR, Lee JB (2003) A case of extraskeletal osteosarcoma with metastasis to the skin. J Am Acad Dermatol 49:124–127CrossRefPubMedGoogle Scholar
  8. Fuchs N, Bielack S, Epler D et al(1998) Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group’s protocol COSS-86 of intensive multi-drug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 9:893–899CrossRefPubMedGoogle Scholar
  9. Goldin A, Serpick AA, Mantel N (1966) Experimental screening procedures and clinical predictability value. Cancer Chemother Rep 50:173–218PubMedGoogle Scholar
  10. Jensen ML, Schumacher B, Jensen OM, Nielsen OS, Keller J (1998) Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases. Am J Surg Pathol 22:588–594CrossRefPubMedGoogle Scholar
  11. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481Google Scholar
  12. Konishi E, Kusuzaki K, Murata H, Tsuchihashi Y, Beabout JW, Unni KK (2001) Extraskeletal osteosarcoma arising in myositis ossificans. Skeletal Radiol 30:39–43CrossRefPubMedGoogle Scholar
  13. Lee JSY, Fetsch JF, Wasdhal DA, Lee BP, Pritchard DJ, Nascimento AG (1995) A review of 40 patients with extraskeletal osteosarcoma. Cancer 76:2253–2259PubMedGoogle Scholar
  14. Logue JP, Cairnduff F (1991) Radiation induced extraskeletal osteosarcoma. Br J Radiol 64:171–172PubMedGoogle Scholar
  15. McCarter MD, Lewis JJ, Antonescu CR, Brennan MF (2000) Extraskeletal osteosarcoma: analysis of outcome of a rare neoplasm. Sarcoma 4:119–123CrossRefGoogle Scholar
  16. Okada K, Ito H, Miyakoshi N, Sageshima M, Nishida J, Itoi E. (2003) A low-grade extraskeletal osteosarcoma. Skeletal Radiol 32:165–169PubMedGoogle Scholar
  17. Salzer-Kuntschik M, Brand G, Delling G (1983) Determination of the degree of morphological regression following chemotherapy in malignant bone tumors. Pathologe 4:135–141PubMedGoogle Scholar
  18. Silver SA, Tavassoli FA (1998) Primary osteogenic sarcoma of the breast: A clinicopathologic analysis of 50 cases. Am J Surg Pathol 22:925–933CrossRefPubMedGoogle Scholar
  19. Sordillo PP, Hajdu SI, Magill GB, Golbey RB (1983) Extraosseous osteogenic sarcoma: a review of 48 patients. Cancer 51:727–734PubMedGoogle Scholar
  20. Winkler K, Beron G, Kotz R et al (1984) Neoadjuvant chemotherapy for osteogenic sarcoma: results of a cooperative German/Austrian study. J Clin Oncol 2:617–623PubMedGoogle Scholar
  21. Winkler K, Beron G, Delling G et al (1988) Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS 82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329–337PubMedGoogle Scholar
  22. Wodowski K, Hill DA, Pappo AS, Shochat SJ, Kun LE, Spunt SL (2003) A chemosensitive pediatric extraosseous osteosarcoma: case report and review of the literature. J Pediatr Hematol Oncol 25(1):73–77CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Sing Yu Goldstein-Jackson
    • 1
    • 2
  • Georg Gosheger
    • 3
  • Günter Delling
    • 4
  • Wolfgang E. Berdel
    • 5
  • G. Ulrich. Exner
    • 6
  • Gernot Jundt
    • 7
  • Jan-Nicolas Machatschek
    • 1
  • Andreas Zoubek
    • 8
  • Heribert Jürgens
    • 1
  • Stefan S. Bielack
    • 1
  • for the Cooperative Osteosarcoma Study Group COSS
    • 1
  1. 1.Klinik und Poliklinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und OnkologieUniversitätsklinikum MünsterMünsterGermany
  2. 2.University of Wales College of MedicineCardiff, WalesUnited Kingdom
  3. 3.Klinik und Poliklinik für Allgemeine OrthopädieUniversitätsklinikum MünsterMünsterGermany
  4. 4.Institut für OsteopathologieUniversitätsklinikum Hamburg-EppendorfHamburgGermany
  5. 5.Medizinische Klinik und Poliklinik AUniversitätsklinikum MünsterMünsterGermany
  6. 6.Orthopädische Universitätsklinik BalgristZürichSwitzerland
  7. 7.Knochentumor-Referenzzentrum am Institut für PathologieUniversitätsspital BaselBaselSwitzerland
  8. 8.St. Anna KinderspitalViennaAustria

Personalised recommendations